Noemí Puig

5 ta ish

Centro de Investigación Biomédica en Red de Cáncer

1. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

   Joaquín Martínez‐López, Juan José Lahuerta, François Pépin +21

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.480111

2. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

   Juan‐José Garcés, María‐Teresa Cedena, Noemí Puig +25

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480203

3. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

   Tomáš Jelı́nek, Renata Bezděková, David Žihala +27

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480213

4. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

   Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva +30

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.881528

5. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

   David Murray, Noemí Puig, Sigurður Y. Kristinsson +10

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.890026